RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21)

<p>This product has been discontinued. Please see below for alternative testing options.<br><br><strong>Comprehensive:</strong><br>* <a href="https://www.neogenomics.com/providers/test/NTG-MDSX-02BX/neo-comprehensive-myeloid-disorders" rel="nofollow">Neo Comprehensive - Myeloid Disorders</a><br>* <a href="https://www.neogenomics.com/providers/test/NTG-HCSX-02BX/neo-comprehensive-heme-cancers" rel="nofollow">Neo Comprehensive - Heme Cancers</a><br><br><strong>Targeted:</strong><br><a href="https://www.neogenomics.com/providers/test/FSH-ETAM-01BX/runx1t1-runx1-eto-aml1-t8-21" rel="nofollow">* RUNX1/RUNX1T1 t(8;21) FISH</a><br><br><strong>Additional Alternative Options:</strong><br>* <a href="https://www.neogenomics.com/providers/test/FLG-AMLX-03BX/aml-mrd-flow-panel" rel="nofollow">AML MRD Flow</a>&nbsp;(Use for monitoring as FISH and NGS do not achieve MRD level sensitivity AML Standard FISH panel)<br><a href="https://www.neogenomics.com/providers/test/NTG-AMEP-02BX/neo-aml-express" rel="nofollow">* Neo AML Express</a><br><br>If you have any questions regarding test discontinuations, please contact your local NeoGenomics Sales Representative or our Client Services team at Client.Services@NeoGenomics.com or call 866.776.5907, option 3.</p>